002030 达安基因
交易中 06-05 09:31:51
资讯
新帖
简况
达安基因(002030)5月29日股东户数15.3万户，较上期增加13.33%
证券之星 · 06-03 17:30
达安基因(002030)5月29日股东户数15.3万户，较上期增加13.33%
达安基因：截至2026年5月29日，公司股东总户数约为15万3千户
证券之星 · 06-03 08:46
达安基因：截至2026年5月29日，公司股东总户数约为15万3千户
达安基因：目前公司主营产品为PCR诊断试剂及相关耗材、仪器等，暂无疫苗相关业务
证券之星 · 06-03 08:46
达安基因：目前公司主营产品为PCR诊断试剂及相关耗材、仪器等，暂无疫苗相关业务
达安基因：公司有埃博拉病毒检测相关科研产品
证券之星 · 05-22
达安基因：公司有埃博拉病毒检测相关科研产品
达安基因：2025年研发投入23,788.26万元
证券之星 · 05-19
达安基因：2025年研发投入23,788.26万元
广药接手达安基因；阿斯利康高血压创新药获美国FDA批准
21世纪经济报道 · 05-19
广药接手达安基因；阿斯利康高血压创新药获美国FDA批准
5月18日达安基因（002030）涨停分析：广药入主、经营改善、产品获批驱动
证券之星 · 05-18
5月18日达安基因（002030）涨停分析：广药入主、经营改善、产品获批驱动
异动快报：达安基因（002030）5月18日9点32分触及涨停板
证券之星 · 05-18
异动快报：达安基因（002030）5月18日9点32分触及涨停板
广药集团旗下将新增上市公司：广药资本公司拟间接控股达安基因
21世纪经济报道 · 05-17
广药集团旗下将新增上市公司：广药资本公司拟间接控股达安基因
达安基因(002030)4月30日股东户数13.5万户，较上期减少4.33%
证券之星 · 05-13
达安基因(002030)4月30日股东户数13.5万户，较上期减少4.33%
达安基因：截至2026年4月30日，公司股东总户数约为13万5千户
证券之星 · 05-13
达安基因：截至2026年4月30日，公司股东总户数约为13万5千户
今日达安基因（002030）涨停分析：控股权变更、业绩改善、产品获批驱动
证券之星 · 05-11
今日达安基因（002030）涨停分析：控股权变更、业绩改善、产品获批驱动
达安基因：截至2026年4月30日，公司股东总户数约为13万5千户
证券之星 · 05-08
达安基因：截至2026年4月30日，公司股东总户数约为13万5千户
异动快报：达安基因（002030）5月8日9点46分触及涨停板
证券之星 · 05-08
异动快报：达安基因（002030）5月8日9点46分触及涨停板
达安基因：中国体外诊断行业市场渗透率仍不高
证券之星 · 04-30
达安基因：中国体外诊断行业市场渗透率仍不高
达安基因（002030）2026年一季报简析：净利润同比下降285.46%，公司应收账款体量较大
证券之星 · 04-29
达安基因（002030）2026年一季报简析：净利润同比下降285.46%，公司应收账款体量较大
图解达安基因年报：第四季度单季净利润同比下降42.71%
证券之星 · 04-28
图解达安基因年报：第四季度单季净利润同比下降42.71%
达安基因：截至2026年3月31日，公司股东总户数约为14万1千户
证券之星 · 04-22
达安基因：截至2026年3月31日，公司股东总户数约为14万1千户
达安基因：截至2026年3月31日，公司股东总户数约为14万1千户
证券之星 · 04-14
达安基因：截至2026年3月31日，公司股东总户数约为14万1千户
股市必读：达安基因（002030）4月8日董秘有最新回复
证券之星 · 04-09
股市必读：达安基因（002030）4月8日董秘有最新回复
加载更多
公司概况
公司名称：
广州达安基因股份有限公司
所属行业：
医药制造业
上市日期：
2004-08-09
主营业务：
广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是分子诊断试剂、生化诊断试剂、免疫诊断试剂、体外诊断仪器。
发行价格：
7.30
{"stockData":{"symbol":"002030","market":"SZ","secType":"STK","nameCN":"达安基因","latestPrice":6.22,"timestamp":1780623111000,"preClose":6.15,"halted":0,"volume":1887300,"delay":0,"changeRate":0.0114,"floatShares":1403000000,"shares":1403000000,"eps":-0.6381,"marketStatus":"交易中","change":0.07,"latestTime":"06-05 09:31:51","open":6.15,"high":6.26,"low":6.15,"amount":11730900,"amplitude":0.0179,"askPrice":6.23,"askSize":10,"bidPrice":6.22,"bidSize":204,"shortable":0,"etf":0,"ttmEps":-0.6381,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1780630200000},"marketStatusCode":2,"adr":0,"adjPreClose":6.15,"symbolType":"stock","openAndCloseTimeList":[[1780623000000,1780630200000],[1780635600000,1780642800000]],"highLimit":6.77,"lowLimit":5.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1403446032,"isCdr":false,"pbRate":1.23,"roa":"--","roe":"--","epsLYR":-0.53,"committee":-0.768895,"marketValue":8729000000,"turnoverRate":0.0013,"status":0,"floatMarketCap":8729000000},"requestUrl":"/m/hq/s/002030/","defaultTab":"news","newsList":[{"id":"2640908354","title":"达安基因(002030)5月29日股东户数15.3万户，较上期增加13.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640908354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640908354?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:30","pubTimestamp":1780479043,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年5月29日公司股东户数为15.3万户，较4月30日增加1.8万户，增幅为13.33%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至5月29日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年4月30日至2026年5月29日，达安基因区间涨幅为22.49%，在此期间股东户数增加1.8万户，增幅为13.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300035470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0188","BK0239","BK0028","BK0042","BK0046","BK0159","002030","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640922682","title":"达安基因：截至2026年5月29日，公司股东总户数约为15万3千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640922682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640922682?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:46","pubTimestamp":1780447572,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至5月29日公司的股东是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。截至2026年5月29日，公司股东总户数约为15万3千户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300009879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0159","BK0168","002030","BK0028","BK0188","BK0122","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640225279","title":"达安基因：目前公司主营产品为PCR诊断试剂及相关耗材、仪器等，暂无疫苗相关业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2640225279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640225279?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:46","pubTimestamp":1780447572,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：非洲埃博拉病毒在蔓延，没有看到好转迹象。贵司研发部门有没有针对此次病毒做前瞻性疫苗研发？达安基因回复：投资者您好，感谢您对达安基因的关注。目前公司主营产品为PCR诊断试剂及相关耗材、仪器等，暂无疫苗相关业务。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300009871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","BK0028","BK0159","BK0239","002030","BK0188","159646","BK0042","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637243362","title":"达安基因：公司有埃博拉病毒检测相关科研产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2637243362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637243362?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:30","pubTimestamp":1779420618,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问：最近刚果金再次爆发埃博拉疫情，公司是否有埃博拉相关检测产品？达安基因回复：投资者您好，感谢您对达安基因的关注！公司有埃博拉病毒检测相关科研产品。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200018938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0159","BK0239","BK0042","BK0188","BK0046","BK0122","002030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636147888","title":"达安基因：2025年研发投入23,788.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636147888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636147888?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:54","pubTimestamp":1779152044,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因05月18日在投资者关系平台上答复投资者关心的问题。2025年，公司研发投入23,788.26万元，占公司营业收入比重31.4%；2025年新增国内外各类注册准入证书57项，其中包含第三类医疗器械注册证书10项；新增授权专利及软件著作权共计46项。关于公司在研项目，请您详见《2025年度报告》中“管理层讨论与分析—研发投入”章节。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900009423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","BK0159","BK0188","BK0028","002030","BK0239","BK0122","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700080","title":"广药接手达安基因；阿斯利康高血压创新药获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700080","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636700080?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:01","pubTimestamp":1779148914,"startTime":"0","endTime":"0","summary":"政策动向2026年医保目录调整新增预申报允许商保创新药申报医保目录国家医保局介绍2026年国家医保药品目录及商业健康保险创新药品目录调整工作安排，包括首次允许纳入2025年商保创新药目录的药品申报国家医保目录，新增“预申报”环节等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605193741160824.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605193741160824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4568","BK0046","LU2237443622.USD","002030","LU0320765992.SGD","LU0289739699.SGD","BK1161","BK0122","IE00B3T34201.USD","LU2237443549.SGD","BK0159","BK4007","LU0109394709.USD","BK1574","LU2237443978.SGD","LU2237443895.HKD","BK4588","159992","BK0188","LU2462157665.USD","LU1829250122.USD","LU2237443465.HKD","LU0889565916.HKD","06978","LU0058720904.USD","AZN","BK4585","LU2456880835.USD","BK0168","BK0028","LU2236285917.USD","LU2417539215.USD","BK0239","BK0042","LABU","LU2237443382.USD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636289250","title":"5月18日达安基因（002030）涨停分析：广药入主、经营改善、产品获批驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2636289250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636289250?lang=zh_cn&edition=full","pubTime":"2026-05-18 15:41","pubTimestamp":1779090112,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因5月18日涨停收盘，收盘价6.64元。5月18日达安基因涨停的可能因素有：广药集团正式接盘公司控股权，实现广州国资体系内资源整合；经营层面亏损持续收窄，低效资产出清完成，治理合规性获审计机构标准无保留意见；年内新获57项医疗器械注册证，覆盖猴痘、禽流感、HIV及多联呼吸道检测等高需求领域；体外诊断行业政策与公卫事件响应预期强化其龙头地位，叠加医疗板块当日集体走强形成联动效应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800016969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","BK0122","BK0159","002030","BK0046","BK0028","BK0188","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636048819","title":"异动快报：达安基因（002030）5月18日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2636048819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636048819?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:37","pubTimestamp":1779068236,"startTime":"0","endTime":"0","summary":"证券之星5月18日盘中消息，9点32分达安基因触及涨停板。其所属行业医疗器械目前下跌。领涨股为奕瑞科技。该股为尼帕病毒，猴痘概念，肝炎概念概念热股，当日尼帕病毒概念上涨1.83%，猴痘概念概念上涨0.39%，肝炎概念概念上涨0.37%。5月15日的资金流向数据方面，主力资金净流出5642.22万元，占总成交额9.6%，游资资金净流出1644.15万元，占总成交额2.8%，散户资金净流入7286.37万元，占总成交额12.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800005199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","BK0042","BK0168","BK0159","BK0188","BK0046","002030","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636099658","title":"广药集团旗下将新增上市公司：广药资本公司拟间接控股达安基因","url":"https://stock-news.laohu8.com/highlight/detail?id=2636099658","media":"21世纪经济报道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636099658?lang=zh_cn&edition=full","pubTime":"2026-05-17 14:39","pubTimestamp":1778999940,"startTime":"0","endTime":"0","summary":"近日，广州达安基因股份有限公司（002030.SZ）发布了《关于间接控股股东拟发生变更的进展公告》，广药集团旗下全资子公司广州广药资本有限公司与达安基因股东广州金控控股集团有限公司、广州生物医药与健康产业投资有限公司及广州广永科技发展有限公司签署了附生效条件的《关于广州达安基因股份有限公司控股权收购协议》等正式交易文件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605173739686185.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605173739686185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0042","BK0188","BK0239","BK0028","BK0122","BK0159","BK0046","BK0168","002030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635920763","title":"达安基因(002030)4月30日股东户数13.5万户，较上期减少4.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635920763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635920763?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:26","pubTimestamp":1778664418,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年4月30日公司股东户数为13.5万户，较3月31日减少6107.0户，减幅为4.33%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至4月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年3月31日至2026年4月30日，达安基因区间跌幅为2.2%，在此期间股东户数减少6107.0户，减幅为4.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300031730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","BK0042","BK0028","002030","BK0159","BK0239","BK0122","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635224228","title":"达安基因：截至2026年4月30日，公司股东总户数约为13万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635224228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635224228?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:43","pubTimestamp":1778632987,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至5月8日公司的股东是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2026年4月30日，公司股东总户数约为13万5千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300007805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0239","BK0159","002030","BK0122","BK0042","BK0028","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634054954","title":"今日达安基因（002030）涨停分析：控股权变更、业绩改善、产品获批驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634054954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634054954?lang=zh_cn&edition=full","pubTime":"2026-05-11 15:42","pubTimestamp":1778485362,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因5月11日涨停收盘，收盘价7.3元。今日达安基因涨停的可能因素有：控股权拟变更至广药集团，强化广州国资背景与产业协同预期；2026年一季报扣非亏损同比收窄，经营性现金流持续为正，降本增效显现；年内新获57项医疗器械注册证，覆盖猴痘、禽流感、呼吸道病原体及HIV检测等多类试剂，产品线加速扩展；公司作为国内分子诊断龙头，全技术平台支撑突发公卫事件快速响应能力获市场关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100016160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0188","BK0046","BK0028","BK0239","BK0122","002030","BK0168","BK0159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633488285","title":"达安基因：截至2026年4月30日，公司股东总户数约为13万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2633488285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633488285?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:34","pubTimestamp":1778211270,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年4月 30日公司的股东总数是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。截至2026年4月30日，公司股东总户数约为13万5千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800017175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","002030","BK0122","BK0239","BK0168","BK0046","BK0159","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633102239","title":"异动快报：达安基因（002030）5月8日9点46分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2633102239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633102239?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:50","pubTimestamp":1778205057,"startTime":"0","endTime":"0","summary":"证券之星5月8日盘中消息，9点46分达安基因触及涨停板。其所属行业医疗器械目前上涨。该股为尼帕病毒，精准医疗，猴痘概念概念热股，当日尼帕病毒概念上涨3.63%，精准医疗概念上涨2.1%，猴痘概念概念上涨1.92%。5月7日的资金流向数据方面，主力资金净流出748.23万元，占总成交额4.39%，游资资金净流入794.35万元，占总成交额4.66%，散户资金净流出46.13万元，占总成交额0.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800010693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","BK0042","BK0168","BK0159","BK0188","BK0046","002030","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631570258","title":"达安基因：中国体外诊断行业市场渗透率仍不高","url":"https://stock-news.laohu8.com/highlight/detail?id=2631570258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631570258?lang=zh_cn&edition=full","pubTime":"2026-04-30 11:30","pubTimestamp":1777519830,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因04月29日在投资者关系平台上答复投资者关心的问题。受市场需求、行业政策等多重因素影响，公司业绩确实面临短期压力与挑战，但参考国外发展水平，中国体外诊断行业市场渗透率仍不高，在人口老龄化、优生优育等趋势下仍具有长期发展潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000038769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0122","BK0159","BK0188","BK0239","BK0046","BK0042","002030","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631644558","title":"达安基因（002030）2026年一季报简析：净利润同比下降285.46%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2631644558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631644558?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:00","pubTimestamp":1777420809,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期达安基因发布2026年一季报。截至本报告期末，公司营业总收入1.49亿元，同比下降11.65%，归母净利润-9815.48万元，同比下降285.46%。本报告期达安基因公司应收账款体量较大，当期应收账款占最新年报营业总收入比达94.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900024652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630311740","title":"图解达安基因年报：第四季度单季净利润同比下降42.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630311740","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630311740?lang=zh_cn&edition=full","pubTime":"2026-04-28 02:40","pubTimestamp":1777315216,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因2025年年报显示，当年度公司主营收入7.58亿元，同比下降11.18%；归母净利润-7.44亿元，同比上升19.54%；扣非净利润-7.72亿元，同比上升6.15%；其中2025年第四季度，公司单季度主营收入2.54亿元，同比下降2.98%；单季度归母净利润-6.03亿元，同比下降42.71%；单季度扣非净利润-4.47亿元，同比下降14.76%；负债率13.46%，投资收益4942.87万元，财务费用-3617.26万元，毛利率32.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800007222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629095686","title":"达安基因：截至2026年3月31日，公司股东总户数约为14万1千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2629095686","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629095686?lang=zh_cn&edition=full","pubTime":"2026-04-22 11:33","pubTimestamp":1776828815,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月20日公司股东人数是多少？谢谢！达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2026年3月31日，公司股东总户数约为14万1千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200025744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0168","BK0239","BK0042","BK0159","BK0188","BK0122","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627191644","title":"达安基因：截至2026年3月31日，公司股东总户数约为14万1千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627191644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627191644?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:54","pubTimestamp":1776156851,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月10日公司股东人数是多少？谢谢！达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2026年3月31日，公司股东总户数约为14万1千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400026728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","002030","BK0028","BK0159","BK0168","BK0239","BK0122","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626592657","title":"股市必读：达安基因（002030）4月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2626592657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626592657?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:00","pubTimestamp":1775667638,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，达安基因报收于6.1元，上涨1.5%，换手率1.12%，成交量15.76万手，成交额9568.74万元。董秘最新回复投资者： 董秘，你好！当日关注点来自交易信息汇总：4月8日主力资金净流入1229.69万元，显示主力对个股短期态度积极。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900000942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0028","BK0046","BK0239","BK0188","BK0042","BK0159","BK0168","BK0122"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780623112382,"stockEarnings":[{"period":"1week","weight":-0.11},{"period":"1month","weight":0.064},{"period":"3month","weight":0},{"period":"6month","weight":-0.0435},{"period":"1year","weight":-0.0032},{"period":"ytd","weight":0.0319}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.0161},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.2019},{"period":"ytd","weight":0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州达安基因股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"153000人(较上一季度增加13.33%)","perCapita":"36144股","listingDate":"2004-08-09","address":"广东省广州市黄埔区高新技术开发区科学城香山路19号","registeredCapital":"140344万元","survey":" 广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是分子诊断试剂、生化诊断试剂、免疫诊断试剂、体外诊断仪器。","listedPrice":7.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达安基因,002030,达安基因股票,达安基因股票老虎,达安基因股票老虎国际,达安基因行情,达安基因股票行情,达安基因股价,达安基因股市,达安基因股票价格,达安基因股票交易,达安基因股票购买,达安基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}